Repligen Director Files Intent to Sell $44k in RGEN Stock
REPLIGEN CORP
Subscribe to track RGEN
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Repligen Director Files Intent to Sell $44k in RGEN Stock
Company: REPLIGEN CORP (RGEN) Form: 144 | Filed: 2025-12-17 Significance: Low
Insider: KAREN A DAWES Title: Director | Relationship: Director
Transaction: • Type: Proposed Sale • Shares: 275 • Price: ~$161.00 • Value: $44,275 • Owned After: Not Disclosed
Key Insight: A director has filed a notice of intent to sell a very small amount of stock, valued at approximately $44k.
Market Context: This transaction is negligible, representing less than 0.001% of the company's $8.58B market cap. It is considered routine and is unlikely to have any market impact.
Comprehensive Analysis
SEC Filing Analysis: REPLIGEN CORP (RGEN)
Executive Summary
- Trading Significance: Low
- Key Takeaway: A director filed a notice of intent for a minor sale of stock, representing an insignificant portion of the company's market capitalization.
- Market Impact: Neutral. The transaction is too small to have any impact on the stock price or trading volume.
Company Information
| Field | Value |
|---|---|
| Company | REPLIGEN CORP |
| Ticker Symbol | RGEN |
| CIK | 0000730272 |
| Industry | BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) |
Insider Information
| Field | Value |
|---|---|
| Name | DAWES KAREN A |
| CIK | 0001261506 |
| Title/Position | Director |
| Relationship | Director |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 144 |
| Transaction Date | 2025-12-17 |
| Transaction Code | S (Proposed Sale) |
| Security Type | Common Stock |
| Shares Involved | 275 |
| Price Per Share | $161.00 |
| Total Value | $44,275 |
| Shares Owned After | Not Disclosed |
| Ownership Type | Not Disclosed |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $44,275 |
| % of Market Cap | <0.001% |
| Shares Transacted | 275 |
| % of Shares Outstanding | <0.001% |
| Post-Transaction Ownership | Not Disclosed |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: The $44,275 transaction is immaterial against Repligen's $8.58 billion market capitalization.
- Transaction Significance: The sale represents a negligible fraction of both the company's market value and its total shares outstanding, indicating it is not a significant event.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: A transaction of this small size is considered routine portfolio management and does not signal any change in the insider's outlook on the company.
Volume & Sentiment
- Expected Volume Impact: None. The number of shares is too small to affect trading volume.
- Sentiment Indicator: Neutral. The filing is unlikely to influence market sentiment.
Additional Context
Transaction Notes
- This Form 144 filing serves as a notice of a proposed sale of securities, not a confirmation of a completed sale.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.